Cell Regeneration Medicine Market Regulatory Framework and Manufacturing Standards
The regulatory landscape for cell regeneration medicine has evolved dramatically since the first cell therapy approvals, transitioning toward comprehensive frameworks that address the unique challenges of living cellular products, personalized manufacturing, and long-term follow-up requirements. The U.S. Food and Drug Administration established the Regenerative Medicine Advanced Therapy (RMAT)...
0 Comments 0 Shares 5 Views 0 Reviews